Abstract OT1-03-05: TROPION-Breast02: Phase 3, Open-Label, Randomized Study of First-Line Datopotamab Deruxtecan Versus Chemotherapy in Patients with Locally Recurrent Inoperable or Metastatic TNBC Who Are Not Candidates for Anti-Pd-(l)1 Therapy